Gang Luo
About Gang Luo
Gang Luo is the Director of Preclinical DMPK & Pharmacology at Supernus Pharmaceuticals, Inc., with previous experience at Charles River Laboratories, DuPont Pharmaceuticals, Bristol-Myers Squibb, and Covance. He holds a PhD in Pharmacology from the University of Illinois at Chicago.
Current Role at Supernus Pharmaceuticals
Gang Luo serves as the Director of Preclinical DMPK & Pharmacology at Supernus Pharmaceuticals, Inc. He has been in this position since 2023, contributing to the company's research and development efforts in Rockville, Maryland. His role involves overseeing preclinical studies and ensuring the pharmacokinetic properties of drug candidates are thoroughly evaluated.
Previous Experience at Charles River Laboratories
Prior to joining Supernus Pharmaceuticals, Gang Luo worked at Charles River Laboratories as the Director of ADME from 2021 to 2023. During his two-year tenure in Mattawan, Michigan, he focused on absorption, distribution, metabolism, and excretion studies, which are critical for drug development.
Professional Background in Pharmaceutical Research
Gang Luo has extensive experience in pharmaceutical research. He worked as a Senior Research Scientist at DuPont Pharmaceuticals from 1998 to 2001 and later held the position of Senior Research Investigator at Bristol-Myers Squibb from 2002 to 2007. He also served as Associate Scientific Director at Covance from 2017 to 2021, where he contributed to various drug development projects.
Educational Qualifications in Pharmacology
Gang Luo earned his Doctor of Philosophy (PhD) in Pharmacology from the University of Illinois at Chicago - Graduate College. His studies took place from 1992 to 1994, providing him with a strong foundation in pharmacological principles that support his career in drug development and research.